Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Sho Endo

Matched on OpenAlex author ID A5100979228. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2017: 6 papers · 2018: 3 papers · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 12

  1. New high-throughput screening detects compounds that suppress pancreatic stellate cell activation and attenuate pancreatic cancer growth. Co-author DOI 10.1016/j.pan.2021.04.002↗
  2. Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion. Co-author DOI 10.1016/j.canlet.2018.12.005↗
  3. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Co-author DOI 10.3892/ijo.2019.4812↗
  4. Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to Postoperative Adjuvant Chemotherapy. Co-author DOI 10.1007/s00268-018-4496-y↗
  5. Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180. Co-author DOI 10.1016/j.canlet.2017.10.010↗
  6. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.03.031↗
  7. Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2017.08.009↗
  8. Clinical importance of intraoperative peritoneal cytology in patients with pancreatic cancer. Co-author DOI 10.1016/j.surg.2016.10.035↗
  9. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  10. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancr… Co-author DOI 10.18632/oncotarget.15430↗
  11. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. Co-author DOI 10.3892/ijo.2016.3829↗
  12. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Co-author DOI 10.3892/ol.2017.6549↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Nakata · 11 shared papers, 2017–2021 · strength 0.72
  2. Kenoki Ohuchida · 11 shared papers, 2017–2021 · strength 0.72
  3. Toshiya Abe · 10 shared papers, 2017–2019 · strength 0.60
  4. Yoshihiro Miyasaka · 10 shared papers, 2017–2019 · strength 0.60
  5. Takao Ohtsuka · 10 shared papers, 2017–2019 · strength 0.60
  6. Takashi Okumura · 9 shared papers, 2017–2019 · strength 0.54
  7. Kazuhiro Koikawa · 9 shared papers, 2017–2019 · strength 0.54
  8. Masafumi Nakamura · 7 shared papers, 2017–2021 · strength 0.48
  9. Hiromichi Nakayama · 7 shared papers, 2017–2019 · strength 0.43
  10. Shin Takesue · 7 shared papers, 2017–2019 · strength 0.43
  11. Chika Iwamoto · 6 shared papers, 2017–2021 · strength 0.42
  12. Yohei Ando · 5 shared papers, 2017–2019 · strength 0.33
  13. Shin Kibe · 5 shared papers, 2017–2019 · strength 0.33
  14. Yoshinao Oda · 5 shared papers, 2017–2019 · strength 0.29
  15. Makoto Hashizume · 5 shared papers, 2017–2018 · strength 0.29
  16. Akiko Sagara · 3 shared papers, 2017–2021 · strength 0.24
  17. Masafumi Nakamura · 4 shared papers, 2017–2018 · strength 0.23
  18. Masafumi Sada · 4 shared papers, 2017–2018 · strength 0.22
  19. Koji Shindo · 2 shared papers, 2019–2021 · strength 0.19
  20. Kohei Horioka · 3 shared papers, 2017–2018 · strength 0.17
  21. Sokichi Matsumoto · 1 shared paper, 2021 · strength 0.11
  22. Naoki Ikenaga · 1 shared paper, 2021 · strength 0.11
  23. Pingshan Zhong · 1 shared paper, 2021 · strength 0.11
  24. Biao Zheng · 2 shared papers, 2017 · strength 0.11
  25. Yusuke Mizuuchi · 2 shared papers, 2017 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.